Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis: British journal of clinical pharmacology

C Liguori, L Ferini-Strambi, F Izzi, L Mari, N Manfredi, A D'Elia, NB Mercuri, F Placidi

Research output: Contribution to journalArticlepeer-review

Abstract

Insomnia is a frequent symptom in depressed patients. It can present with difficulty in initiating and/or maintaining sleep. We retrospectively evaluated a group of 15 patients affected by major depressive disorder (MDD) and complaining for insomnia, who started Vortioxetine (VOR) treatment for their depressive symptoms. The following questionnaires were captured at baseline and follow-up: Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and Beck Depression Inventory (BDI). PSQI total score significantly decreased between baseline and follow-up (p
Original languageEnglish
Pages (from-to)240-244
Number of pages5
JournalBritish Journal of Clinical Pharmacology
Volume85
Issue number1
DOIs
Publication statusPublished - 2019

Fingerprint Dive into the research topics of 'Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis: British journal of clinical pharmacology'. Together they form a unique fingerprint.

Cite this